Gene based prediction of clinically localized prostate cancer progression after radical prostatectomy

Journal of Urology

Volumn 184, Issue 4, 2010, Pages 1521-1528

  Talantov, Dmitri ^a   Jatkoe, Timothy A ^a   Bhm, Maret ^b   Zhang, Yi ^a   Ferguson, Alison M ^b   Stricker, Phillip D ^c   Kattan, Michael W ^e   Sutherland, Robert L ^b   Kench, James G ^b,d   Wang, Yixin ^a   Henshall, Susan M ^b  

^a Veridex LLC   (United States)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

nomograms; prostate; prostate specific antigen; prostatic neoplasms; risk

Indexed keywords

ACTIN; CALDESMON; DICKKOPF 1 PROTEIN; FILAMIN A; FORMALDEHYDE; GELSOLIN; HISTONE H1; METALLOTHIONEIN I; MYOSIN; PARAFFIN; PROSTATE SPECIFIC ANTIGEN; SINGLE STRANDED DNA BINDING PROTEIN; SMOOTHELIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER RECURRENCE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; NOMOGRAM; PDZ DOMAIN; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; STATISTICAL MODEL;

DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 84755160806     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.05.084     Document Type: Article

References (30)

1. L.A.G. Ries, D. Melbert, and M. Krapcho SEER Cancer Statistics Review, 19752005 2008 National Cancer Institute, posted to the SEER web site Bethesda
2. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2008 CA Cancer J Clin 58 2008 71
3. M.R. Cooperberg, J.W. Moul, and P.R. Carrol The changing face of prostate cancer J Clin Oncol 23 2005 8146
4. T.J. Wilt SPCG-4: a needed START to PIVOTal data to promote and ProtecT evidence-based prostate cancer care J Natl Cancer Inst 100 2008 1123
5. P.T. Scardino Localized prostate cancer is rarely a fatal disease Nat Clin Pract Urol 5 2008 1
6. S. Kumar, M. Shelley, and C. Harrison Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer Cochrane Database Syst Rev 2006 CD006019
7. T.H. Van der Kwast, M. Bolla, and H. Van Poppel Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911 J Clin Oncol 25 2007 4178
8. S.F. Shariat, P.I. Karakiewicz, and N. Suardi Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature Clin Cancer Res 14 2008 4400
9. M. Graefen, P.I. Karakiewicz, and I. Cagiannos Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer J Clin Oncol 20 2002 951
10. A.J. Stephenson, P.T. Scardino, and J.A. Eastham Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Clin Oncol 23 2005 7005
11. M.W. Kattan, T.M. Wheeler, and P.T. Scardino Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer J Clin Oncol 17 1999 1499
12. G.V. Glinsky, A.B. Glinskii, and A.J. Stephenson Gene expression profiling predicts clinical outcome of prostate cancer J Clin Invest 113 2004 913
13. S.M. Henshall, D.E. Afar, and J. Hiller Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse Cancer Res 63 2003 4196
14. J. Lapointe, C. Li, and J.P. Higgins Gene expression profiling identifies clinically relevant subtypes of prostate cancer Proc Natl Acad Sci U S A 101 2004 811
15. T. Nakagawa, T.M. Kollmeyer, and B.W. Morlan A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy PloS ONE 3 2008 e2318
16. D. Singh, P.G. Febbo, and K. Ross Gene expression correlates of clinical prostate cancer behavior Cancer Cell 1 2002 203
17. Y.P. Yu, D. Landsittel, and L. Jing Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy J Clin Oncol 22 2004 2790
18. S. Setlur, K. Mertz, and Y. Hoshida Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer J Natl Cancer Inst 100 2008 815
19. S. Henshall, L. Horvath, and D. Quinn Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy J Natl Cancer Inst 98 2006 1420
20. L. Mucci, Y. Pawitan, and F. Demichelis Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort Cancer Epidemiol Biomarkers Prev 17 2008 1682
21. D.I. Quinn, S.M. Henshall, and R.L. Sutherland Molecular markers of prostate cancer outcome Eur J Cancer 41 2005 858
22. M. Bibikova, D. Talantov, and E. Chudin Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays Am J Pathol 165 2004 1799
23. F. Ohl, M. Jung, and C. Xu Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization? J Mol Med 83 2005 1014
24. F.E. Harrell Jr Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis 2001 Springer-Verlag New York
25. M.Y. Park, and T. Hastie L1 regularization path algorithm for generalized linear models J R Stat Soc Series B Stat Methodol 69 2007 659
26. V.G. Tusher, R. Tibshirani, and G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci U S A 98 2001 5116
27. R.D.C. Team R: A Language and Environment for Statistical Computing 2007 R Foundation for Statistical Computing Vienna
28. S. Joniau, and H. Van Poppel Localized prostate cancer: can we better define who is at risk of unfavourable outcome? BJU Int 101 2008 S5
29. M. Bolla, H. van Poppel, and L. Collette Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572
30. D. Mazhar, and J. Waxman Early chemotherapy in prostate cancer Nat Clin Pract Urol 5 2008 486